STAGE III INTRAHEPATIC CHOLANGIOCARCINOMA AJCC V8
Clinical trials for STAGE III INTRAHEPATIC CHOLANGIOCARCINOMA AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE III INTRAHEPATIC CHOLANGIOCARCINOMA AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE III INTRAHEPATIC CHOLANGIOCARCINOMA AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Early trial pairs radiation blitz with immune drug for tough liver cancer
Disease control OngoingThis early-stage study is testing the safety and best dose of a two-part treatment for advanced bile duct cancer that has spread. Patients receive a short, intense course of radiation to one tumor, followed by an immunotherapy drug designed to help the immune system attack the ca…
Matched conditions: STAGE III INTRAHEPATIC CHOLANGIOCARCINOMA AJCC V8
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New 'Smart Bomb' drug trial offers hope for Tough-to-Treat bile duct cancer
Disease control OngoingThis study is testing a drug called sacituzumab govitecan in people with advanced bile duct cancer (cholangiocarcinoma) that has come back or spread after at least one prior treatment. The drug is designed to target cancer cells specifically, delivering a toxic agent directly to …
Matched conditions: STAGE III INTRAHEPATIC CHOLANGIOCARCINOMA AJCC V8
Phase: PHASE2 • Sponsor: University of Kansas Medical Center • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New drug combo tested for Tough-to-Treat liver cancer
Disease control OngoingThis study is testing whether a new drug called pevonedistat can help control advanced bile duct cancer that starts in the liver. It is being tested alone and in combination with two standard chemotherapy drugs (carboplatin and paclitaxel) in about 40 patients whose cancer has wo…
Matched conditions: STAGE III INTRAHEPATIC CHOLANGIOCARCINOMA AJCC V8
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New hope for Tough-to-Treat bile duct cancers
Disease control OngoingThis study is for people with advanced bile duct, gallbladder, or liver bile duct cancer that has worsened after initial treatment. It tests whether adding a targeted pill called binimetinib to standard chemotherapy (FOLFOX) helps patients live longer and better control the cance…
Matched conditions: STAGE III INTRAHEPATIC CHOLANGIOCARCINOMA AJCC V8
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 09, 2026 14:26 UTC